18-FDG positron emission tomography of the pancreas: Diagnostic benefit in the follow-up of pancreatic carcinoma

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2437-2442

  Franke, C ^a   Klapdor, R ^a   Meyerhoff, K ^a   Schauman, M ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

18 FDG positron emission tomography; Pancreatic carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; TUMOR MARKER;

ADULT; AGED; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ECHOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MALE; PANCREAS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; BLOOD GLUCOSE; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032808255     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, Buchler MW: Diagnosis of pancreatic cancer by 2(18F)-fluoro2-deoxy-D-glucose positron emission tomography. Gut 37(3): 448, 1995.
2. Inokuma T, Tamaki N, Torizuka T, Magata Y, Fujii M, Yonekura Y, Kajiyama T, Ohshio G, Imamura M, Konishi J: Evaluation of pancreatic tumours with positron emission tomography anf F-18 fluorodeoxyglucose: comparison with CT and US. Radiology 795(2): 345-52, 1995.
3. Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Imamura M, Konishi J: Contribution of PET in the detection of liver metastases from pancreatic tumours. Clin Radiol 54(4): 248-52, 1999.
4. Rajput A, Stellato TA, Faulhaber PF, Veselle HJ, Miraldi F: The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease. Surgery 124(4): 793-7, 1998.
5. Rink T, Schroder O, Dietrich C, Kirchner J, Hor G, Zeuzem S, Baum RP: Long-term follow-up and therapeutic control of a hepatic metastatic acinar cell carcinoma of the pancreas using FDG PET. Nuclearmedizin 37(5): 187-91, 1998.
6. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg MJ, Modiano MR, Cripps MC, Portenay RK, Storniolo AM, Tarassoff P, Nelson R, Dorr A, Stephens CD, von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997.
7. Klapdor R, Seutter E, Lang-Pölckow EM, Reichle H, Hinrichs A: Locoregional/systemic chemotherapy of locally advanced/ metastasized pancreatic cancer with a combination of mitomycin-C and Gemcitabine and simultaneous follow-up by imaging methods and tumor markers. In press. Anticancer Res 19: 2459-2470, 1999.